November 2022 Publications
- Evaluation of the consistence between the results of immunoinformatics predictions and real-world animal experiments of a new tuberculosis vaccine MP3RT. Cheng P, Xue Y, Wang J, Jia Z, Wang L, Gong W. Front Cell Infect Microbiol. 2022 Nov 2. doi: 10.3389/fcimb.2022.1047306. eCollection 2022.
- Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants. Satti I, Wittenberg RE, Li S, Harris SA, Tanner R, Cizmeci D, Jacobs A, Williams N, Mulenga H, Fletcher HA, Scriba TJ, Tameria M, Haterill M, McShane H. Nat Comm. 2022 Nov 3. Doi: 10.1038/s41467-022-34601-7
- Challenges in TB research. Scriba TJ, Dinkele R, Warner DF, Mizrahi V. J Exp Med. 2022 Nov 3. Doi: 10.1084/jem.20221334. Online ahead of print.
- Immunologic Role of Innate Lymphoid Cells against Mycobacterial tuberculosis Infection. Narinyan W, Poladian N, Orujyan D, Gargaloyan A, Venketaraman V. Biomedicines. 2022 Nov 6. doi: 10.3390/biomedicines10112828.
- Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis. Jayawardana S, Weerasuriya CK, Pelzer PT, Seeley J, Harris RC, Tameris M, Tait D, White RG, Asaria M. NPJ Vaccines. 2022 Nov 7. doi: 10.1038/s41541-022-00554-1
- Histopathologic differences in granulomas of Mycobacterium bovis bacille Calmette Guérin (BCG) vaccinated and non-vaccinated cattle with bovine tuberculosis. Kanipe C, Boggiatto, PM, Putz EJ and Palmer, MV. Front Microbiol. 2022 Nov 8. doi: 10.3389/fmicb.2022.1048648
- Mycobacterium tuberculosis: Implications of Ageing on Infection and Maintaining Protection in the Elderly. Bonavida V, Frame M, Nguyen KH, Rajurkar S, Venketaraman V. Vaccines(Basel). 2022 Nov 9. doi:10.3390/vaccines10111892
- Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses. Coccia M, Burny, W, Demoitie MA, Gillard P, van den Berg RA, van der Most R. 2022 Nov 10. PLoS One. doi: 10.1371/journal.pone.0276505
- Enhanced immunogenicity of Mycobacterium bovis BCG through CRISPRi mediated depletion of AftC. Madduri BTSA, Allen L, Taylor SC, Besra GS, Alderwick LJ. Cell Surf. 2022 Nov 11. doi: 10.1016/j.tcsw.2022.100088. eCollection 2022 Dec.
- National TB elimination programme – What has changed. Khanna A, Saha R, Ahmad N. 2022 Nov 16. Indian J Med Microbiol. doi: 10.1016/j.ijmmb.2022.10.008
- BCG vaccinations drive epigenetic changes to the human T cell receptor: Restored expression in type 1 diabetes. Takahashi H, Kuhtreiber WM, Keefe RC, Lee AH, Aristarkhova A, Dias HF, Ng N, Nelson KJ, Bien S, Scheffrey D, Faustman DL. Sci Adv. 2022 Nov 18. doi: 10.1126/sciadv.abq7240
- Activation of Nrf2 modulates protective immunity against Mycobacterium tuberculosis infection in THP1-derived macrophages. Zhou J, Fang F, Qi J, Li T, Zhang L, Liu H, Lv J, Xu T, Wu F, Song C, Li W, Wang X, Chang X, Wang H, Wang T, Qian Z. Free Radic Biol Med. 2022 Nov 20. doi: 10.1016/j.freeradbiomed.2022.10.274. Epub 2022 Oct 14.
- Can BCG vaccination at first health-facility contact reduce early infant mortality? Study protocol for a cluster-randomised trial (CS-BCG). Thysen SM, Jensen AM, Vedel JO, da Silva Borges I, Aaby P, Jensen AKG, Benn CS, Fisker AB. BMJ. 2022 Nov 21. doi: 10.1136/bmjopen-2022-063872
- Pathogenicity and virulence of Mycobacterium tuberculosis. Rahlwes Kathryn C, Dias Beatriz RS, Campos Priscila C, Alvarez-Arguedas S, Shiloh Michael U. Virulence. 2022 Nov 23. doi: 10.1080/21505594.2022.2150449. Online ahead of print.
- Advance in strategies to build efficient vaccines against tuberculosis. Qu W, Guo Y, Xu Y, Zhang J, Wang Z, Ding C, Pan Y. Front Vet Sci. 2022 Nov 24. doi: 10.3389/fvets.2022.955204.
- Manganese enhances macrophage defense against Mycobacterium tuberculosis via the STING-TNF signaling pathway. Qian K, Shan L, Shang S, Li T, Wang S, Wei M, Tang B, Xi J. Int Immunopharmacol. 2022 Nov 23. doi: 10.1016/j.intimp.2022.109471. Online ahead of print
- First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world. Lu J, Zhang X, Xu H, Li Z. Hum Vaccin Immunother. 2022 Nov 30. doi: 10.1080/21645515.2022.2080443